65984-53-4

Basic information

• Product Name: 3-(4-broMophenyl)propan-1-aMine
• Synonyms: 3-(4-broMophenyl)propan-1-aMine;4-BroMo-benzenepropanaMine;BENZENEPROPANAMINE, 4-BROMO-
• CAS NO: 65984-53-4
• Molecular Formula: C₉H₁₂BrN
• Molecular Weight: 214.10228
• Mol File: 65984-53-4.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 108 °C(Press: 1 Torr)
• Appearance: /
• Density: 1.349±0.06 g/cm3(Predicted)
• PKA: 10.19±0.10(Predicted)
• CAS DataBase Reference: 3-(4-broMophenyl)propan-1-aMine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-broMophenyl)propan-1-aMine(65984-53-4)
• EPA Substance Registry System: 3-(4-broMophenyl)propan-1-aMine(65984-53-4)

Safety Data

• Hazardous Substances Data: 65984-53-4(Hazardous Substances Data)

Usage

General Description

3-(4-bromophenyl)propan-1-amine is a chemical compound with the molecular formula C9H12BrN. It is an amine compound with a phenyl group substituted with a bromine atom. This chemical is used in the production of pharmaceuticals, agrochemicals, and other organic compounds. It is also commonly used as a building block in organic synthesis. The compound is a white to off-white solid and is typically stored and handled under controlled conditions to prevent exposure to air and moisture. It is important to handle this compound with care as it may be harmful if swallowed, inhaled, or comes into contact with skin.

Upstream product

• 27549-93-5 (E)-3-(4-bromophenyl)acrylonitrile 
• 589-87-7 1,4-bromoiodobenzene 
• 1643-30-7 3-(4-bromophenyl)propionic acid 
• 4592-94-3 3-(4-bromophenyl)-3-oxopropanenitrile 
• 106-37-6 1.4-dibromobenzene 
• 1200-07-3 3-(4-bromophenyl)acrylic acid 
• 13565-09-8 4-bromocinnamoyl chloride 
• 130973-06-7 p-bromocinnamamide 
• 65984-59-0 3-(4-bromophenyl)-3-hydroxypropanenitrile 
• 57775-08-3 3-(4-Bromo-phenyl)-propionitrile 
• 4654-39-1 4-bromophenethanol 
• 1746-28-7 1-bromo-4-(2-bromoethyl)benzene 

Downstream Products

• 713541-85-6 N-[3-(4-bromophenyl)propyl]-N,N-dicyclobutylamine 
• 150932-97-1 N-[3-(4-Bromo-phenyl)-propyl]-benzamide 
• 65984-66-9 N,N'-Bis-<3-(p-bromphenyl)propyl>-thioharnstoff 

Relevant articles and documents

FERROPTOSIS INHIBITORS–DIARYLAMINE PARA-ACETAMIDES

Provided are compounds that inhibit ferroptosis activity, or modulate or inhibit a disease associated with ferroptosis dysregulation, such as neuropathy, ischemia reperfusion injury, acute kidney failure and cancer, including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.

Transition-metal-free Intramolecular C-H amination of sulfamate esters and: N -alkylsulfamides

The transition-metal-free intramolecular C-H amination of sulfamate esters using iodine oxidants, tert-butyl hypoiodite (t-BuOI) and N-iodosuccinimide (NIS) is reported. A method using NIS was also successfully applied to the oxidative cyclization of N-alkylsulfamides.

N-phenpropylcuclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase

The invention relates to compounds of formula (I) for treating for example sexual dysfunction, wherein R1 is optionally substituted C1-6alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, hydrogen, C1-6alkoxy, —NR2 R3 or —NR4SO2R5; X is the linkage —(CH2)n— or —(CH2)q—O— (wherein Y is attached to the oxygen); wherein one or more hydrogen atoms in linkage X may be replaced independently by C1-4alkoxy; hydroxy; hydroxy(C1-3alkyl); C3-7cycloalkyl; carbocyclyl; heterocyclyl; or by C1-4alkyl optionally substituted by one or more fluoro or phenyl groups; n is 3, 4, 5, 6 or 7; and q is 2, 3, 4, 5 or 6; and Y is phenyl or pyridyl, each of which may be substituted; or two R8 groups on adjacent carbon atoms together with the interconnecting carbon atoms may form a fused optionally substituted 5- or 6-membered carbocyclic or heterocyclyic ring.